PharmaShots | Incisive News in 3 Shots

Subscribe Now

Hemolytic Uremic Syndrome

Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Atypical Hemolytic Uremic Syndrome

Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Atypical Hemolytic Uremic Syndrome

June 29, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us